Holen Sie sich die Stockscreener-App
12.45
5.51%
0.65
Vorhandelsmarkt:
12.45
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Eversept Partners LP Lowers Stake in Bioventus Inc. $BVS - MarketBeat
315,018 Shares in Bioventus Inc. $BVS Bought by Engine Capital Management LP - MarketBeat
BlackRock (BVS) discloses 3.4M-share, 5.02% passive stake in Bioventus - Stock Titan
Is Bioventus (BVS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
BVS|Bioventus Inc|Price:12.460|Chg%:+0.660 - TradingKey
Bioventus Inc (BVS) Balance Sheet - TradingKey
Bioventus Inc (BVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioventus Inc (BVS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioventus Inc (BVS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BVS|Bioventus Inc|Price:11.800|Chg%:+0.320 - TradingKey
TradingKey - TradingKey
Bioventus, Inc. (BVS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
Does Bioventus (BVS) Have the Potential to Rally 28.92% as Wall Street Analysts Expect? - Yahoo Finance
161,926 Shares in Bioventus Inc. $BVS Acquired by Fifth Third Bancorp - MarketBeat
Bioventus Inc (BVS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Understanding the Setup: (BVS) and Scalable Risk - Stock Traders Daily
Bioventus Inc (BVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bioventus (BVS) Upgraded to Buy: Here's Why - Yahoo Finance
Should Value Investors Buy Bioventus (BVS) Stock? - Yahoo Finance
Bioventus (BVS) Q4 2025 earnings summary - Quartr
Bioventus (BVS) Proxy filing Summary - Quartr
Bioventus (BVS) Q3 2024 earnings summary - Quartr
Bioventus (BVS) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary - Quartr
Bioventus (BVS) Q2 2024 earnings summary - Quartr
Bioventus (BVS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Bioventus (BVS) Q1 2026 earnings summary - Quartr
Bioventus (BVS) Corporate presentation Summary - Quartr
Bioventus, Inc. (BVS) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
A Look at Bioventus Inc (BVS) After 4.1% Decline -- GF Value $6. - GuruFocus
Bioventus Down Nearly 9%, On Pace for Largest Percent Decrease Since May 2025 -- Data Talk - Moomoo
Bioventus Inc. (BVS) Slides 1.93% as Selling Pressure Tests Near-Term Support LevelsBullish Percent Index - dars.gov.et
Bioventus (NASDAQ:BVS) Reaches New 12-Month HighHere's Why - MarketBeat
Hillsdale Investment Management Inc. Raises Stake in Bioventus Inc. $BVS - MarketBeat
Bioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
Bioventus Q1 2026 Earnings: EPS Beat Exceeds Estimates, But Stock SlipsPositive Surprise Momentum - dars.gov.et
Bioventus Slips Amid Selling Pressure: Key Levels to Watch for BVSFair Value Gap - dars.gov.et
Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks - Yahoo Finance
Bioventus, Inc. Class A Actuals & Estimates (LSX:A2APNA) - TradingView
Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice - Yahoo Finance
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16 - Moomoo
Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know - Yahoo Finance
Bioventus Deadline Alert - TMX Newsfile
A2APNA Forecast — Price Target — Prediction for 2027 - TradingView
A2APNA Stock Price and Chart — LSX:A2APNA - TradingView
Bioventus: I See A Better Business Trading At A Fair Price (Upgrade) (NASDAQ:BVS) - Seeking Alpha
BioventusTargeting Earnings Growth Outpacing Revenue Growth In 2026 - RTTNews
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Zacks.com featured highlights include First Advantage, Bioventus and Ooma - Yahoo Finance
Bioventus stock surges on favorable 2027 outpat... - Pluang
Bioventus shares rise after Medicare reverses reimbursement cuts By Investing.com - Investing.com Canada
Bioventus shares rise after Medicare reverses reimbursement cuts - Investing.com
Bioventus Shareholder Action Reminder - TMX Newsfile
Bioventus Shareholder Notice - TMX Newsfile
Total liabilities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Free cash flow of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Cash flow from investing activities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Net debt of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Non-operating income (total) of Bioventus, Inc. Class A – LS:A2APNA - TradingView
EBIT of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Cash flow from operating activities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Operating income of Bioventus, Inc. Class A – LS:A2APNA - TradingView
0.79%
4.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):